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Abstract
Mammals adapted to a great variety of habitats with different accessibility to water. In addition to changes in kidney
morphology, e.g. the length of the loops of Henle, several hormone systems are involved in adaptation to limited water
supply, among them the renal-neurohypophysial vasopressin/vasopressin receptor system. Comparison of over 80
mammalian V2 vasopressin receptor (V2R) orthologs revealed high structural and functional conservation of this key
component involved in renal water reabsorption. Although many mammalian species have unlimited access to water there
is no evidence for complete loss of V2R function indicating an essential role of V2R activity for survival even of those species.
In contrast, several marsupial V2R orthologs show a significant increase in basal receptor activity. An increased vasopressin-
independent V2R activity can be interpreted as a shift in the set point of the renal-neurohypophysial hormone circuit to
realize sufficient water reabsorption already at low hormone levels. As found in other desert mammals arid-adapted
marsupials show high urine osmolalities. The gain of basal V2R function in several marsupials may contribute to the
increased urine concentration abilities and, therefore, provide an advantage to maintain water and electrolyte homeostasis
under limited water supply conditions.
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Introduction
Over a period of 170 million years of mammalian evolution
species adapted to a great variety of habitats with different
accessibility to water. Several mammals managed adaptation to
conditions of water restriction among them desert rodents and
elephants. Interestingly, elephants still present anatomical and
physiological features of their evolutionary origin as aquatic
animals [1,2]. Other closely related mammals such as Baikal and
California seals managed adaptation to fresh and sea water
conditions, respectively. There is strong evidence that, besides
morphological modifications in the kidney [3,4], several hormone
systems [5], among them the renal-neurohypophysial hormone
system of vasopressin, are involved in adaptation to differences in
fresh water supply [6].
The peptides of the vasotocin/vasopressin/oxytocin family are
evolutionary old hormones which are already found in agnate
bony and cartilaginous fishes [7–9]. At least one homolog each of
vasopressin and oxytocin (mesotocin, isotocin) is found in jawed
vertebrates whereas jawless vertebrates possess vasotocin [10].
Along with the divergence of the vasopressin/oxytocin peptides
their receptors developed co-evolutionary and in mammals at least
two of the various vasopressin receptor subtypes and one oxytocin
receptor became established within all the genomes investigated so
far. All members of the vasopressin receptor family belong to the
superfamily of rhodopsin-like G protein-coupled receptors
(GPCR). In mammals V1 vasopressin receptors (V1aR, V1bR)
are involved in blood pressure regulation and central feedback
mechanism whereas the V2 vasopressin receptor (V2R) maintains
the water balance and electrolyte homeostasis.
The V2R is mainly expressed in kidney and regulates
aquaporin-2-mediated water reabsorption via activation of the
Gs protein/adenylyl cyclases/cAMP pathway. Vasopressin recep-
tor function specialized in the regulation of water and electrolyte
homeostasis is obviously linked to the evolution of tetrapods [11]
but there is evidence that vasopressin-regulated cAMP formation
is already present in fishes [12].
The importance of the vasopressin/V2R system in the
hypothalamic-renal regulation of the water and electrolyte
homeostasis becomes evident when one of the components is
inactivated. For example, inactivating mutations of the V2R gene
cause an inherited form of nephrogenic diabetes insipidus (NDI)
[13]. NDI is characterized by the inability to concentrate the urine
and an increased urine volume. Inherited NDI is not only found in
humans but also in mice, dogs and horses [14–16] indicating
similar functional relevance of the V2R among mammals.
PLoS ONE | www.plosone.org 1 May 2009 | Volume 4 | Issue 5 | e5573However, there are several examples where patients managed
NDI basically by appropriate water supply (family 4 in [17] and
family 1 in [18]). This may suggest that partial or even full loss of
V2R function is tolerated in species with free access to fresh water.
An opposite phenotype, the nephrogenic syndrome of inappro-
priate antidiuresis (NSIAD), is seen when V2R is altered by
activating mutations. Here, the phenotype is characterized by
serum hypoosmolarity and high urinary sodium levels [19]. This
may suggest that increased activity of V2R provides some
advantage in concentrating the urine in order to save water under
dry environmental conditions. One can speculate that the limited
alimentary water supply prevents serum hypoosmolarity in desert
animals, a sign found in patients with NSIAD under water-ad-
libitum conditions.
According to allosteric ternary complex models of receptor
activation [20], V2R, like all GPCR, exists in an equilibrium
between inactive and active conformations. The models predict
that, even in the absence of agonist, a certain fraction of receptors
will spontaneously adopt an active conformation, permitting
agonist-independent G-protein activation. Agonist binding to the
free receptor leads to stabilization of the activated form of the
receptor that is able to couple to the G protein. Inverse agonists
decrease the spontaneous activity of receptors by shifting the
equilibrium towards the inactive stage. Like agonists or inverse
agonists, activating or inactivating mutations are capable of
shifting the equilibrium toward active and inactive conformations,
respectively. The fact that structural variations of the V2R may
have an impact on basal activity, efficacy and potency gives rise to
a spectrum of adaptive functionalities.
Here, we set out to analyze whether structural and functional
properties of mammalian V2R correlate to different environmen-
tal conditions. We focused on V2R rather than on the hormone
vasopressin because it is also involved in blood pressure regulation
and the latter physiological function may restrict the adaptive
variability of the peptide hormone. Thus, 87 V2R ortholog
sequences were retrieved from mammalian species, some existing
in extreme habitats. This sequence information enabled us to
identify motifs and residues that are important for maintaining the
receptor function. Our functional studies provide evidence that
increased basal V2R activity is probably responsible for increased
basal urine concentration ability in some desert-living marsupials.
Results and Discussion
Public sequence databases were mined for mammalian genomic
V2R sequences. We further increased the sequence information by
fully or partially cloning of additional V2R orthologs (see
Supporting Material Table S1) with special focus on mammalian
species living in desert environments and habitats with water
excess. The sequence information of 87 full-length or partially
Figure 1. Genomic structure of mammalian V2R and evolutionary conservation of intron/exon boundaries. To determine the
conservation of the genomic structure, the sequence of 87 mammalian V2R genes were retrieved by cloning from genomic DNA and by mining
public databases. During 170 million years of mammalian evolution the genomic structure of three coding exons was preserved. There is
experimental evidence that the V2R gene of several mammals including the human V2R gene contains an additional non-coding exon in 59 position
(not shown). Sequence alignments of the exon/intron boundaries indicate high conservation of the splice donor and acceptor sites. The positions of
NDI-causing splice site mutations are marked with an asterisk.
doi:10.1371/journal.pone.0005573.g001
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structural parameters of the V2R gene and protein which are
relevant for maintaining receptor’s function.
Preservation of the genomic structure of the V2R in
mammals
Previous studies have shown that some structural variability of
V2R is generated by receptor splice variants e.g. in rodents [21–23].
Further, mutations of splice sites within the V2R gene (AVPR2) were
found to be the cause of inherited NDI [24–27]. Therefore, we
analyzed the genomic structure of mammalian V2R genes in
respect to the conservation of splice donor and acceptor sites.
Three exons encode for the human V2R [28] and this genomic
structure appears to be evolutionary preserved among mammals
(see Figure 1). The second intron is ancient and is found not only
in V2R genes of birds and mammals but also in other members of
the vasopressin/oxytocin receptor family at the same position
[29,30]. The first intron was probably introduced in the very early
mammalian evolution because it is found in platypus, marsupial
and other mammalian but not in avian V2R genes.
Although the intron sizes vary between 117 bp and 757 bp for
intron 1 and 75 bp and 534 bp for intron 2, the core sequences of
the donor and acceptor sites in mammalian V2R genes are highly
conserved (see Figure 1). All three mutations in the human V2R
proposed to affect pre-mRNA splicing [31] are at splice site
positions that are 100% conserved during mammalian evolution.
High structural conservation of V2R in mammals
The overall identity between full-length mammalian V2R
orthologs (36 species) is 85.966.7% (see Table 1). During 170
million years of mammalian evolution ,160 (,43.1%) out of all
amino acid residues in V2R remained unchanged between
mammalian species (Figure 2). The overall structural conservation
of V2R (84.668.0%) is not significantly different when compared
with comparable ortholog data sets of other GPCR (20 identical
species): rhodopsin (94.362.2%), the melanocortin type 4 receptor
(MC4R) (93.164.8%), the ADP receptor P2Y12 (88.865.3% )
and GPR34 (85.467.5% ) [32–34].
Detailed analysis revealed the following results:
First, we found several length variations within the extracellular
and intracellular loops (see Table 1). The length variations of the
third intracellular loop (ICL3) were most prominent (Figure 3).
Although ICL3 has been implicated in G-protein activation,
desensitization and interaction with other signalling components in
other GPCR, ICL3 of the V2R shows low amino acid sequence
conservation. In several species the middle part of ICL3 contains
sequence deletions up to 11 amino acids (marsupials) and
insertions of 16 amino acids (platypus) when compared to the
human V2R. This implicates a rather low functional relevance of
the middle portion of the ICL3 in V2R. Indeed, deletion of the
respective 11 amino acids in the human V2R (referred to as
human del243–253) had no effect on receptor function (Table 2).
Additional evidence for a rather low functional relevance of the
middle portion of ICL3 comes from split receptors. V2R
fragments split in ICL3 reassemble functionally when coexpressed
[35]. Further, a naturally occurring 12-bp deletion including
amino acid positions 247 to 250 was reported to have no
functional relevance in the human V2R [36].
Second, the N terminus is most diverse in its length and amino acid
sequencebetweenmammalianorthologs(Table1)clearlyindicating
less specific relevance in ligand binding and in receptor activity.
Third, the C terminus of the human V2R contains two Cys
residue (Cys
341, Cys
342) which allows anchoring via palmitoylation
and forming a fourth intracellular loop (ICL4). It was demon-
strated by mutagenesis of the two Cys residues that palmitoylation
of V2R is important for intracellular trafficking and/or seques-
tration/internalization. Most efficient reduction of receptor cell
surface expression was found when Cys
341 alone or both Cys
residues were mutated [37]. Consistently, Cys at position 341 is
100% conserved in mammals whereas Cys
342 is substituted by
Arg, Trp and Phe in several mammalian species.
Fourth, a proposed glutamate/dileucine motif equivalent
(E
335LRSLL
340 in human V2R) in the C terminus [38] is highly
preserved during mammalian V2R evolution. The motif may
represent a transport signal from the endoplasmic reticulum to the
Golgi apparatus. Leu
339 was found substituted by Trp and Leu
340
by Phe in some V2R orthologs keeping with the hydrophobic
nature of ICL4 [39].
Fifth, most rhodopsin-like GPCR possess an evolutionarily
conserved Asp-Arg-Tyr (DRY) motif in the C-terminal region of
TMD3. Mutations of the first two residues within this motif usually
alter receptor function and, when they occur naturally, can even
cause diseases. In V2R the DRY motif is a DRH which is highly
conserved in mammals and only the manatee has DRQ. Variation
of the Tyr residue in the DRY motif appears to be functionally
tolerated since this position is variable in many GPCR and
substitution of Tyr has no or marginal effects in most cases [40].
Sixth, phosphorylation plays a pivotal role in the regulation of
GPCR function. Previous studies identified putative sites which are
clustered in the C terminus and in ICL3 and are phosphorylated
by specific GPCR kinases (GRK) and by protein kinase A (PKA),
respectively [41–43]. Whereas abundant putative Ser/Thr phos-
phorylation sites are found in the C terminus of all V2R orthologs
the putative PKA phosphorylation site within ICL3 at Ser
255 [41]
is substituted by Asn, Gly and Asp in many V2R orthologs
Table 1. Structural comparison of mammalian V2R orthologs.
Domain Length (Min/Max)
Conservation between
mammalian orthologs (%
Identity)
Full length 365/381 85.966.7
N terminus 35/40 67.2612.3
C terminus 43/48 80.969.6
ECL1 15 91.565.6
ECL2 24/26 78.8612.4
ECL3 15 84.0610.4
ICL1 14/15 84.568.7
ICL2 23/24 91.167.6
ICL3 39/59 80.7613.2
TMD1 24 87.968.4
TMD2 21 96.263.7
TMD3 22 99.062.4
TMD4 20 94.966.2
TMD5 23 94.266.1
TMD6 21 97.062.5
TMD7 21 97.263.6
The amino acid sequence information of 36 full-length V2R orthologs (see
Supporting Material Table S1) was used to determine global and more distinct
structural parameters. Segment lengths (minimum/maximum) and the
structural conservation between mammalian orthologs (given as % identity
determined by Clustal W implemented in MegAlign of Lasergene Ver. 7.1.0) are
shown. Data are given as mean6S.D.
doi:10.1371/journal.pone.0005573.t001
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only a few species.
Evaluation of naturally occurring mutations in the human
V2R
As stated above, several NDI patients carrying an inactivating
V2R mutation managed the disease by sufficient fresh water
supply without any medications. One can speculate that V2R
function is less important when a species lives in a water-ad-libitum
environment. Therefore, we analyzed whether NDI-causing
(inactivating) variants of the human V2R naturally occur in other
mammalian V2R orthologs. To date, about 113 missense variants
of the human V2R at 90 amino acid positions have been described
(see Supporting Material Table S3) [31,44]. Out of these missense
variants 91% are assumed to be NDI causing. We correlated this
information with the evolutionary variability at the respective
amino acid position (Figure 2, Table 3). About 91% of all NDI-
causing mutations hit positions that are fully conserved or vary
between two amino acids (Table 3). None of the NDI-causing
variants was found in any of the mammalian V2R orthologs.
Therefore, our analysis provided no evidence of inactivating
mutations in the mammalian V2R orthologs investigated.
Adaptive gain-of-function in marsupial V2R orthologs
Conservation and variability of distinct positions can only be
properly interpreted in the light of functional data of different
orthologs. Therefore, a number of mammalian V2R orthologs
were cloned, expressed in COS-7 cells, stimulated with arginine
Figure 2. Structural conservation of the mammalian V2R. The amino acid sequence of the human V2R is shown. Positions conserved in
mammalian V2R orthologs are depicted in dark grey. Positions which vary only by two amino acids are shown in light gray. Positions given in white
are not preserved in mammals. For the N-terminal part (position 1 to 64, numbering refers to the human V2R amino acid sequence) we analyzed 38
ortholog sequences, for the middle part (position 65 to 322) 87 sequences and for the C-terminal part (position 323–371) 42 sequences. Over 103
missense mutations were identified in NDI patients, most affected highly conserved amino acid residues (positions are encircled in black) (see also
Table 3).
doi:10.1371/journal.pone.0005573.g002
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shown in Table 2, AVP potencies (EC50) at the selected V2R
orthologs varied between 115 pM (Californian sea lion) and
841 pM (dog) and were in a comparable range to findings with the
human V2R (238 pM). There is no obvious correlation of the
agonist potencies to the environmental conditions of the respective
species. Our data may reflect the naturally tolerated range of
vasopressin potency between roughly 0.1 and 1 nM. Consistently,
there is no report where an exclusive increase in EC50 values of
lower than one order of magnitude causes NDI.
Species differences were found for the efficacy of receptor
signaling. Several aquatic mammals (Baikal seal, Californian sea
lion, minke whale, Caribbean manatee), cattle and some gerbils
(Wagner’s gerbil, bushy-tailed jird) displayed reduced Emax values
when compared with the human V2R (see Table 2). The reduced
Emax values are most likely caused by reduction in cell surface
expression levels of these V2R orthologs. For the Baikal seal V2R,
one can discuss this as some reduction of constraint because of free
access to fresh water and, therefore, as a reduced necessity to
concentrate the urine. However, the reduced efficacy of V2R
signal transduction in marine mammals (Californian sea lion,
minke whale, Caribbean manatee) and gerbils is unexpected
because these animals produce highly concentrated urine, which is
especially important for mammals in a hyperosmotic and desert
environment, respectively. Variations in kidney morphology
observed in marine mammals does not appear to afford them
any greater benefit than terrestrial mammals, suggesting that the
adaptation of mammals to sea water was accomplished also via
hormonal regulation of urine concentration and/or the rate of
urine formation [45]. The anti-diuretic function of AVP in marine
mammals is still inconclusive. AVP levels in dolphins and seals are
rather low despite high urine osmolality [45]. In sum, it is unlikely
that the reduced signaling efficacy of V2R in some aquatic
mammals and gerbils is a result of evolutionary adaptation. It
rather reflects the naturally occurring spectrum of V2R function
or a reduced constraint at the V2R because of other adaptive
mechanisms to concentrate the urine.
Striking differences were found in the basal activity of marsupial
V2R orthologs. All marsupial V2R showed elevated basal activity
ranging from 2.2 to 4.3-fold over the human and all other V2R
orthologs tested (Figure 4A, Table 2). The orthologs of arid-adapted
species, red kangaroo and agile wallaby, displayed the highest basal
activity and a significant gain in receptor efficiency. ELISA studies
exclude that the increased basal activity was due to higher cellsurface
Figure 3. The ICL3 varies between mammalian V2R orthologs. Sequence analysis of V2R orthologs revealed a remarkable length and amino
acid variation of ICL3. Positions which differ from the amino acid sequence of human V2R are boxed.
doi:10.1371/journal.pone.0005573.g003
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Species
basal cAMP
(% human V2R)
Emax
(% human V2R) EC50 (pM)
Cell surface
expression
# (%
human V2R)
Total cellular
expression
## (%
human V2R)
Primates
human 100 (21) 100 (21) 238.3660.7 (18) 100 (21) 100 (15)
human del243–253 122.4613.9 (9) 96.3614.2 (9) 184.8634.8 (8) 104.962.9 (11) 109.165.4 (4)
common gibbon 88.668.3 (7) 114.267.7 (7) 497.36101.7 (7) 96.763.2 (6) 103.261.7 (5)
crab-eating macaque 119.767.0 (8) 120.5616.9 (8) 760.06187.6 (8) 102.166.4 (9) 93.863.0 (5)
African green monkey 94.9618.6 (7) 78.3613.5 (7) 266.7653.9 (7) 98.165.7 (10) 106.665.2 (4)
Rodentia
house mouse 106.6612.0 (14) 102.768.3 (14) 231.8647.6 (14) 89.164.5 (11) 108.563.2 (9)
Algerian grass mouse 114.0612.2 (8) 91.4614.0 (8) 368.6676.5 (8) 90.963.3 (8) 111.663.6 (5)
muskrat 111.368.6 (9) 87.468.3 (9) 211.7665.9 (8) 74.362.6 (7) 107.961.8 (4)
golden hamster 101.7624.8 (6) 94.2617.4 (6) 175.3636.2 (6) 92.864.5 (8) 108.663.5 (7)
Northern mole vole 78.7613.7 (10) 69.9611.1 (10) 386.4691.0 (10) 96.664.2 (6) 103.763.9 (5)
steppe lemming 107.9624.7 (8) 86.2618.9 (8) 324.2692.1 (8) 100.564.6 (8) 108.163.1 (7)
bushy-tailed jird 118.8626.6 (7) 46.167.4 (7)* 404.4665.2 (7) 58.766.8 (10) 103.063.1 (5)
Mongolian gerbil 108.9610.0 (8) 93.8611.4 (8) 268.1653.4 (7) 91.163.4 (7) 106.865.5 (3)
Wagner’s gerbil 124.2624.0 (6) 63.5611.9 (7)* 265.9680.7 (7) 71.564.5 (7) 104.664.4 (5)
large naked-sole gerbil 106.5616.9 (6) 108.3610.1 (6) 216.3639.9 (6) 90.363.3 (8) 101.265.6 (4)
lesser Egyptian jerboa 127.7617.2 (8) 110.3612.9 (8) 678.7699.7 (8) 101.164.7 (7) 102.962.2 (7)
greater Egyptian jerboa 109.9620.3 (7) 98.2612.3 (7) 738.76172.6 (7) 102.566.3 (8) 110.162.4 (5)
Japanese squirrel 97.2611.0 (10) 91.866.7 (10) 470.4684.2 (10) 83.263.4 (5) 96.164.4 (4)
Carnivora
lion 92.167.2 (20) 95.7611.4 (20) 586.0674.5 (20) 73.966.3 (10) 93.165.3 (9)
dog 101.867.1 (10) 124.6613.8 (10) 841.36232.7 (10) 95.063.2 (7) 88.867.3 (5)
Eurasian river otter 107.0615.0 (15) 91.9612.7 (15) 306.9664.2 (15) 83.464.8 (8) 103.861.6 (9)
Baikal seal 113.068.0 (14) 74.966.3 (14) 131.5640.6 (14) 67.465.2 (7) 103.861.7 (9)
Californian sea lion 105.668.1 (14) 70.066.2 (14) 114.8641.3 (14) 65.168.9 (7) 101.862.5 (9)
Cetacea
minke whale 111.6622.6 (7) 62.1610.1 (7)* 294.9677.8 (6) 37.065.8 (8) 86.1612.7 (7)
Proboscidea
Asiatic elephant 117.7618.0 (8) 79.7619.4 (8) 210.6665.1 (8) 55.165.6 (6) 99.363.1 (5)
African savanna elephant 109.6618.2 (9) 78.3615.1 (9) 300.8686.3 (9) 49.364.5 (7) 96.762.0 (8)
Sirenia
Caribbean manatee 115.7618.7 (13) 53.766.8 (13)* 147.2625.5 (13) 31.763.4 (7) 101.563.0 (5)
Macroscelidea
short-eared elephant shrew 102.3626.0 (8) 81.1618.6 (8) 375.7653.6 (8) 67.763.5 (6) 81.3612.4 (6)
Artiodactyla
cattle 101.066.5 (16) 62.167.1 (16)* 154.0643.0 (15) 56.567.2 (11) 78.666.0 (9)
Marsupials
Didelphimorphia
North American opossum 224.9666.7 (8) 168.1635.4 (8) 483.86207.9 (5) 106.569.9 (7) 99.161.0 (6)
Diprotodontia
red kangaroo 433.0665.6 (8)* 193.5627.9 (8)* 340.06107.6 (5) 129.066.8 (7) 98.561.5 (6)
agile wallaby 340.6649.4 (8)* 185.1620.6 (9)* 340.1681.6 (6) 123.065.7 (8) 97.562.2 (7)
long-nosed potoroo 314.2665.8 (9)* 107.3622.0 (9) 256.16118.2 (6) 57.366.0 (8) 96.361.7 (7)
For functional characterization COS-7 cells were transiently transfected with V2R constructs and non-radioactive cAMP assays were performed as described in Materials
and Methods.E max and EC50 values were determined from concentration-response-curves of AVP (1 fM–10 mM) using GraphPad Prism. Data are presented as
mean6S.E.M. of independent experiments (number indicated in parentheses), each carried out in duplicate. Cyclic AMP levels of non-stimulated (10.062.2 amol/cell)
and 10 mM AVP-stimulated (185.9628.6 amol/cell) human V2R served as reference basal and Emax values and were set 0% and 100%, respectively. Cell surface and total
expression levels of V2R orthologs were measured by cell surface and total cellular ELISAs (see Materials and Methods). Specific optical density (OD) readings (OD value
of HA-tagged construct minus OD value of GFP-transfected cells) are given as a percentage of human double HA/FLAG-tagged V2R.
#For the cell surface ELISA the non-specific OD value (GFP) was 0.01360.007 (set 0%) and the OD value of the human V2R was 0.98360.133 (set 100%).
##For the total cellular ELISA the non-specific OD value (GFP) was 0.06160.020 (set 0%) and the OD value of the human V2R was 0.81460.118 (set 100%). The number
of independent experiments, each carried out in quadruplicate, is given in parentheses.
*indicates significance differences (p,0.01) to the average basal and AVP-induced activity of all V2R orthologs.
doi:10.1371/journal.pone.0005573.t002
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the transfected plasmid DNA indicating genuine constitutively active
receptors (Figure 4B). The increase in basal activity of e.g. the red
kangaroo V2R was comparable to basal cAMP levels found in
patients with NSIAD [19]. Besides basal activity, marsupial V2R
displayed normal V2R function and cellular expression levels
(Table 2). When compared to all other mammalian V2R orthologs
tested the kangaroo V2R contains 23 positions with amino acids that
are unique to marsupial orthologs (see Supporting Material Figure
S2). Thirteen of them are at positions which are 100% conserved
among all other non-marsupial V2R orthologs. Unfortunately, there
is no obvious individual position known to cause constitutive activity
when substituted. It is more likely, that sequential or combinatorial
substitutions at the sequence background of the marsupial V2R
orthologs lead to increased basal receptor function. This hypothesis is
supported by the fact that constitutive activity differed significantly
between marsupial V2R orthologs (see Table 2).
Severalmarsupials,liketheredkangarooandtheagilewallaby,are
adapted to extremely dry climates. Most marsupials display a typical
mammalian pattern of hormonal control of kidney function and
water excretion, with plasma vasopressin levels correlating highly
with the urine/plasma osmolality ratio [46]. However, their renal
ability to reabsorb water and concentrate the urine is extraordinary
high. For example, hare wallaby and red kangaroo have average
urine osmolalities between 1,843 and 2,357 mosmol kg
21 [47] and
red kangaroo can concentrate up to 4,000 mosmol kg
21 [48]. For
comparison, average human urine osmolality is 800 mosmol kg
21
and human kidneys can concentrate the urine up to 1,400 mos-
mol kg
21. Although some studies suggest that mammals with
relatively long loops of Henle for their body size tend to have greater
than average urinary concentrating ability [49,50], detailed analyses
found no relationship between urine osmolality and absolute length of
the loop of Henle [4,51]. Moreover, a recent report found that one
desert wallaby (Petrogale rothschildi) appears to be unique amongst
mammals lacking antidiuretic response to vasopressin [47]. There-
fore, other factorsthan morphological and hormonal mustcontribute
to adaption of the renal water reabsorption to the different water
accessibilities. An increased agonist-independent V2R function, as
found for marsupials, can be interpreted as a shift in the set point of
the renal-neurohypophysial hormone circuit to realize sufficient
water reabsorption already at low hormone levels. Similarly,
increased basal activity is physiologically found also for the thyroid
stimulating hormone (TSH) receptor, the MC1R and the MC4R to
assure basal thyroid hormone production, pigmentation and energy
homeostasis, respectively [52–54]. One may argue that increased
basal V2R activity in marsupials should have pathophysiological
consequences as found in NSIAD patients. However, serum
hypoosmolality in these patients results from normal alimentary
water intake but inadequate renal water elimination. In contrast to
humans one can not expect an ad libitum supply of water for desert
marsupials. Therefore, serum hypoosmolality, as observed in NSIAD
patients carrying an activating V2R mutation, is probably unlikely.
This example nicely demonstrates the biological interpretation of a
specific protein function (e.g. basal activity) as an advantage
(adaptation) or a disadvantage (disease) depending on environmental
conditions.
Conclusion
The V2R is a key component in regulating the renal water
reabsorption but its contribution to adaptation of mammals to
different water accessibility was not investigated yet. We found
that the mammalian V2R is highly conserved in its amino acid
structure and functional properties. Although some mammals have
unlimited access to fresh water there is no evidence for complete
loss of V2R function in those or any other mammals investigated.
This indicates that some V2R activity is essentially required for
species survival. In contrast, structural changes in the marsupial
V2R resulted in a gain of V2R function and may provide an
advantage to maintain water and electrolyte homeostasis for those
marsupials living in arid habitats.
Materials and Methods
V2 vasopressin receptor ortholog identification and site-
directed mutagenesis
To analyze the sequence of V2R orthologs, genomic DNA
samples were prepared from tissue or peripheral mononuclear
blood cells of various mammalian species (sources are given in
Supporting Material Table S1). Tissue samples were digested in
lysis buffer (50 mM Tris/HCl, pH 7.5, 100 mM EDTA, 100 mM
NaCl, 1% SDS, 0.5 mg/ml proteinase K) and incubated at 55uC
for 18 hours. DNA was purified by phenol/chloroform extraction
and ethanol precipitation. Degenerated primer pairs (Supporting
Material Table S2) were applied to amplify V2R specific
sequences. PCR reactions were performed with Taq polymerase
under variable annealing and elongation conditions. Specific PCR
products were directly sequenced and/or subcloned for sequenc-
ing into the pCR2.1-TOPO vector (Invitrogen, La Jolla, CA).
Sequencing reactions were performed with a dye-terminator cycle
sequencing kit (Applied Biosystems) on an ABI 3700 automated
sequencer (Applied Biosystems). Based on considerable sequence
similarities of the 59- and 39-untranslated regions (UTR) of V2R
genes primers were designed (Supporting Material Table S2)
which allowed for the identification of some sequences encoding
the N and C termini of mammalian V2R orthologs.
Full-length V2R were inserted into the mammalian expression
vector pcDps (Scho ¨neberg et al 1996) and epitope-tagged with an
N-terminal hemagglutinin (HA) epitope and a C-terminal FLAG-
tag by a PCR-based overlapping fragment mutagenesis approach.
For most species only genomic DNA was available for V2R
ortholog cloning. Therefore, most mammalian V2R constructs
were build by inserting a genomic DNA fragment containing the
second intron (encompassing amino acid position 68 (2.33,
numbering of the relative position within GPCR [55]) to amino
acid position 321 (7.49) of the respective mammalian ortholog into
the double-tagged human V2R-pcDps expression plasmid keeping
the human N and C termini. Identity of all constructs and
correctness of all PCR-derived sequences were confirmed by
Table 3. Function-conservation relationship of natural
occurring missense mutations in V2R.
Variability of the position Wild-type function NDI causing
.2 amino acids 4 9
2 amino acids 4 11
1 amino acid 2 83
More than 113 missense mutations at 90 positions within the human V2R have
been described (see Figure 2). About 91% of all V2R missense variants identified
so far are NDI causing. The table gives a correlation between the functional
consequence of individual mutations and the evolutionary conservation of the
mutated position. The complete list of missense mutations included in the
analysis and the references are given in Supporting Material Table S3. The
evolutionary conservation of each mutated position was determined by
aligning V2R orthologs available and the variability of the position was
categorized in three groups from no variation (1 amino acid) to high variation
(.2 amino acids) in mammalian orthologs.
doi:10.1371/journal.pone.0005573.t003
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are functionally equivalent to expression constructs of the full-
length cDNA, the different constructs were compared in cAMP
assays. As shown in Supporting Material Figure S1 function of
cDNA constructs (dog, bovine) were identical to constructs
containing the TMD core and second intron of the respective
species flanked by the human N and C termini.
Cell culture and functional assays
COS-7 cells were grown in DMEM supplemented with 10%
fetal bovine serum, 100 U/ml penicillin, and 100 mg/ml strepto-
mycin at 37uC in a humidified 7% CO2 incubator. Lipofectami-
ne
TM (Invitrogen) was used for transient transfection of COS-7
cells. Thus, cells were split into 50-ml cell culture flasks (1610
6
cells per flask) and transfected with 4 mg of plasmid DNA/flask.
ALPHAScreen
TM cAMP assay. cAMP content of cell
extracts was determined by a non-radioactive cAMP
accumulation assay based on the ALPHAScreen
TM technology
according to the manufacturer’s protocol (Perkin Elmer LAS,
Rodgau-Ju ¨gesheim, Germany) [56]. One day after transfection
cells were split into 48-well plates (5610
4 cells/well). Stimulation
with various agonist concentrations ([Arg8]-vasopressin acetate
salt from Sigma-Aldrich, Seelze, Germany) was performed 48 h
after transfection for 1 h at 37uC. Reactions were stopped by
aspiration of media and cells were lysed in 50 ml of lysis buffer
containing 1 mM 3-isobutyl-1-methylxanthine. From each well
5 ml of lysate were transferred to a 384-well plate. Acceptor beads
(in stimulation buffer without 3-isobutyl-1-methylxanthine) and
donor beads were added according to manufacturers’ protocol.
Cyclic AMP accumulation data were analyzed using GraphPad
Figure 4. Increased basal activity of marsupial V2R orthologs. For functional characterization of the human and marsupial V2R orthologs, the
respective expression plasmids were transfected into COS-7 cells and tested for AVP-induced cAMP accumulation. A) 48 hours after transfection cells
were stimulated with increasing concentrations of AVP. Intracellular cAMP was measured with AlphaScreen cAMP assay (see Materials and Methods).
B) To further assess the increased basal activity of marsupial V2R orthologs increasing amounts of plasmid DNA from the red kangaroo ortholog were
transfected and cAMP assays were performed. As expected for a constitutive active receptor, basal receptor activity correlates with the amount of
transfected plasmid DNA. Data are given as mean6S.E.M. of three experiments each performed in duplicate.
doi:10.1371/journal.pone.0005573.g004
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California, USA).
ELISA studies. To estimate cell surface expression of
receptors carrying an N-terminal HA-tag, we used an indirect
cellular ELISA [57]. To further assess the amounts of full-length
double-tagged V2Rs, a sandwich ELISA was used essentially as
described previously [17]. Briefly, microtiter plates were coated
with a polyclonal anti-FLAG antibody and cell lysates were
applied. Following intensive washing with PBS containing 0.05%
Triton X-100 (PBS-T), plates were incubated with a peroxidase-
labeled monoclonal anti-HA antibody (12CA5; 1 mg/mL PBS-T).
After removal of excess unbound conjugate, H2O2 and o-
phenylenediamine (2.5 mmol/L each in 0.1 mol/L phosphate/
citrate buffer, pH 5.0) were added to serve as substrate and
chromogen, respectively. After 15 min, the enzyme reaction
(carried out at room temperature) was stopped by the addition
of 1 mol/L H2SO4 containing 0.05 mol/L Na2SO3, and colour
development was measured bichromatically at 492 and 620 nm
using an ELISA reader (Sunrise
TM, Tecan Group Ltd.).
Data deposition
The sequences reported in this paper have been deposited in the
GeneBank database (accession no. FJ411185-FJ411251; Support-
ing Material Table S1).
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